Inactive Instrument

All News INSMED Nasdaq

Equities

US4576692085

End-of-day quote Nasdaq Other stock markets
- ^USD	-

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

INSMED : to Participate in the Stifel Healthcare Conference 2013	13-09-04	PU
INSMED : to Participate in August Investor Conferences	13-08-07	PU
INSMED : Reports Second Quarter Financial Results	13-08-06	PU
INSMED : to Host Second Quarter 2013 Financial Results Conference Call on Tuesday, August 6, 2013	13-07-31	PU
INSMED : Appoints Christine Pellizzari as General Counsel and Corporate Secretary	13-07-29	PU
INSMED : Announces Closing of Public Offering and Exercise of Option to Purchase Additional Shares	13-07-22	PU
INSMED : Announces Pricing of Public Offering of Common Stock	13-07-17	PU
INSMED : Announces Proposed Public Offering of Common Stock	13-07-15	PU
INSMED : to Present at the 8th Annual JMP Securities Healthcare Conference	13-07-08	PU
INSMED : ARIKACE Meets Primary Endpoint of Non-Inferiority to TOBI in Phase 3 Clinical Trial in Europe and Canada to Treat Pseudomonas aeruginosa in Cystic Fibrosis Patients	13-07-01	PU
INSMED : to Report Top-Line Results From Phase 3 Clinical Trial of ARIKACE to Treat Pseudomonas Aeruginosa in Cystic Fibrosis	13-06-28	PU
INSMED : to Join the Russell Global(R) and Russell 3000(R) Indexes	13-06-28	PU
INSMED : Granted Key Composition of Matter Patent Allowance for ARIKACE in Europe	13-05-14	PU
INSMED : to Present at the UBS Global Healthcare Conference	13-05-13	PU
INSMED : to Present at the Bank of America Merrill Lynch 2013 Health Care Conference	13-05-10	PU
INSMED : Reports First Quarter Financial Results	13-05-07	PU
INSMED : to Host First Quarter 2013 Financial Results Conference Call on Tuesday, May 7, 2013	13-05-01	PU
INSMED : to Present at the 12th Annual Needham Healthcare Conference	13-04-18	PU
INSMED : Appoints Matthew Pauls as Chief Commercial Officer	13-04-01	PU
INSMED : ARIKACE Receives Orphan Drug Designation for Treating Infections Caused by Non-Tuberculous Mycobacteria	13-03-28	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News INSMED Nasdaq

Equities

US4576692085

All News

Filters